These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 3436113)

  • 1. Serum fructosamine level as a marker of glycemic control in diabetic patients with and without a residual C-peptide secretion.
    Buysschaert M; Ketelslegers JM; Mpoy M; Galanti L; Pirson F; Pouthier F; Lambert AE
    Diabetes Res; 1987 Nov; 6(3):129-31. PubMed ID: 3436113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Home blood glucose monitoring, glycosylated hemoglobin and fructosamine: their relationships in diabetic patients with and without residual C-peptide secretion.
    Brichard SM; van den Abbeele E; Ketelslegers JM; Lambert AE
    Diabete Metab; 1989; 15(6):388-93. PubMed ID: 2628041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of fructosamine with glycated hemoglobin as an index of glycemic control in diabetic patients.
    Guillausseau PJ; Charles MA; Godard V; Timsit J; Chanson P; Paolaggi F; Peynet J; Eschwege E; Rousselet F; Lubetzki J
    Diabetes Res; 1990 Mar; 13(3):127-31. PubMed ID: 2091880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relevance of persistent C-peptide secretion in type 1 (insulin-dependent) diabetes mellitus to glycaemic control and diabetic complications.
    Winocour PH; Jeacock J; Kalsi P; Gordon C; Anderson DC
    Diabetes Res Clin Pract; 1990 Apr; 9(1):23-35. PubMed ID: 2351037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Level of serum fructosamine in Saudi diabetic patients.
    Ajabnoor MA; Zawawi TH; Marzouki KM; Marzouki ZM
    Acta Diabetol Lat; 1990; 27(2):105-12. PubMed ID: 2378195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of fructosamine with glycosylated hemoglobin and plasma proteins as measures of glycemic control.
    Smart LM; Howie AF; Young RJ; Walker SW; Clarke BF; Smith AF
    Diabetes Care; 1988 May; 11(5):433-6. PubMed ID: 3391095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum fructosamine concentration as measure of blood glucose control in type I (insulin dependent) diabetes mellitus.
    Baker JR; Metcalf PA; Holdaway IM; Johnson RN
    Br Med J (Clin Res Ed); 1985 Feb; 290(6465):352-5. PubMed ID: 3917816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of serum fructosamine as index of short-term glycemic control in diabetic outpatients.
    Cefalu WT; Parker TB; Johnson CR
    Diabetes Care; 1988 Sep; 11(8):662-4. PubMed ID: 3219971
    [No Abstract]   [Full Text] [Related]  

  • 9. [2,070 simultaneous determinations of blood glucose, glucosylated hemoglobin and fructosamine as index of metabolic control in 519 diabetic patients].
    Gómez Reyes D; Gea T; Rojas Hidalgo E
    Rev Clin Esp; 1989 Nov; 185(7):354-8. PubMed ID: 2623250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum fructosamine and glycated haemoglobin measurements in diabetic control.
    Hindle EJ; Rostron GM; Clark SA; Gatt JA
    Arch Dis Child; 1986 Feb; 61(2):113-7. PubMed ID: 3954436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of plasma fructosamine in the assessment of diabetic control.
    Saeed BO; elWali NM; Atabani GS; Elmahdi EM; Mukhtar E
    Trop Geogr Med; 1991; 43(1-2):51-4. PubMed ID: 1750129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylated hemoglobin and fructosamine. Indicators of glycemic control in pregnancies complicated by diabetes mellitus.
    Watson WJ; Herbert WN; Prior TW; Chapman JF
    J Reprod Med; 1991 Oct; 36(10):731-4. PubMed ID: 1956013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Response of insulin and C-peptide to a mixed meal in non-insulin-dependent diabetics treated with insulin and chlorpropamide].
    García-Rubi E; Alemán-Hoey DD
    Rev Invest Clin; 1995; 47(1):21-8. PubMed ID: 7777712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term performance of the fructosamine assay.
    Dominiczak MH; Macrury SM; Orrell JM; Paterson KR
    Ann Clin Biochem; 1988 Nov; 25 ( Pt 6)():627-33. PubMed ID: 3254102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum fructosamine/haemoglobin A1 ratio predicts the future changes in haemoglobin A1 in type 2 (non-insulin dependent) diabetic patients.
    MacRury SM; Kilpatrick ES; Paterson KR; Dominiczak MH
    Clin Chim Acta; 1991 May; 199(1):51-8. PubMed ID: 1934502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of serum fructosamine activity in type I diabetic children.
    Cefalu WT; Mejia E; Puente GR; Fleishhacker D; Macaulay K
    Am J Med Sci; 1989 Apr; 297(4):244-6. PubMed ID: 2705464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Goals and assessment of diabetic control.
    Scott DJ; Cooper GJ
    N Z Med J; 1985 Jul; 98(782):536-8. PubMed ID: 3897925
    [No Abstract]   [Full Text] [Related]  

  • 18. Glycated serum protein determination: comparison between thiobarbituric acid and fructosamine assays.
    Poli T; Lapolla A; Plebani M; Franchin A; Fedele D
    Acta Diabetol Lat; 1987; 24(3):241-7. PubMed ID: 3687316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of reliability of plasma fructosamine and glycosylated hemoglobin assays for assessing glycemic control in diabetic patients on hemodialysis.
    Nunoi K; Kodama T; Sato Y; Iwase M; Yoshizumi H; Kurimoto H; Nishitani H; Nakamura S; Fujishima M
    Metabolism; 1991 Sep; 40(9):986-9. PubMed ID: 1895965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fructosamine assay: an index of medium-term metabolic control parameters in diabetic disease.
    Lapolla A; Poli T; Barison A; Fedele D
    Diabetes Res Clin Pract; 1988 Feb; 4(3):231-5. PubMed ID: 3359924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.